cGMPs or Current Good Manufacturing Practices is a general encompassing term for the regulations that the control of all facets of life sciences manufacturing processes and facilities particularly pharmaceutical products.
It is crucial, for any entity to be compliant, that every individual within the organization fully understand and adhere to these regulations.
Adherence to those regulations assures the identity, strength, quality, and purity of drug products by requiring that manufacturers of medications adequately control manufacturing operations.
This includes establishing strong quality management systems, obtaining appropriate quality raw materials, establishing robust operating procedures, detecting and investigating product quality deviations, and maintaining reliable testing laboratories. This formal system of controls if adequately put into practice, helps to prevent instances of contamination, mix-ups, deviations, failures, and errors. This assures that drug and medical device products meet their quality standards.
The cGMP requirements were established to be flexible in order to allow each manufacturer to decide individually how to best implement the necessary controls by using scientifically sound design, processing methods, and testing procedures. The flexibility in these regulations allows companies to use modern technologies and innovative approaches to achieve higher quality through continual improvement.
Accordingly, the 'c' in cGMP stands for 'current,' requiring companies to use technologies and systems that are up-to-date in order to comply with the regulations. Systems and equipment that may have been 'top-of-the-line' to prevent contamination, mix-ups, and errors 10 or 20 years ago are less than adequate by today's standards.
It is important to note that cGMPs are minimum requirements. Many manufacturers are already implementing comprehensive, modern quality systems and risk management approaches that exceed these minimum standards.
Why Should you Attend
Understanding GMP requirements, refreshed on a yearly basis is critical to maintain high-GMP standards in your company. Knowledge and skill surrounding the application and practice of GMPs is fundamental to avoiding regulatory issues. It's simple - you have to do it and you and your team must comply.
You cannot assume that once taught, the content associated with GMPs will be retained from year to year. As human beings, we tend to forget over time and as we forget, we also get careless. In the health sciences there is no margin for error or tolerance for carelessness. This training will provide foundation to your GMP training.
SEMINAR OBJECTIVES
List and describe the regulations governing Good Manufacturing Practices
State the personal responsibilities as they relate to GMPs.
List and describe the regulations in the 21 CFR regulations that pertain to GMPs.
Explain how to prepare for a GMP inspection
List and describe the consequences of not being prepared for an FDA inspection
Explain how the FDA inspection is structured and conducted
Explain how the organization should be structured for the FDA Inspection
Explain the importance of truthfulness when interacting with FDA inspectors
List and describe the tricks inspectors use to elicit information
Explain how employees should behave during an inspection
Explain how organizations should handling adverse findings at the completion of an inspection
Key Topics Covered:
DAY 1 (11 AM to 3 PM)
GMPs - Government Regulations
What are the regulations governing Good Manufacturing Practices?
Your responsibilities
Pertinent GMP topics as per the code of Federal Regulations
Quality Management
Personnel
Premises and equipment
Documentation
Production
Quality Assurance
Materials management
Production and in-process controls
Packaging and labeling
Storage and distribution
Laboratory controls
Validation
Change control
Rejection and re-use of material
Complaints and recalls
Supplier controls
DAY 2 (11 AM to 3 PM)
GMP Inspections
Preparing for a GMP Inspection
The consequences of not being ready
The specific areas that are inspected during a GMP inspection
DAY 3 (11 AM to 3 PM)
GMP Inspections
The FDA Inspection - how is it structured and conducted
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the Phase II/III SKYSCRAPER-06 study, evaluating tiragolumab plus Tecentriq® (atezolizumab) and chemotherapy versus pembrolizumab and chemotherapy as an initial...
BenevolentAI ("BenevolentAI" or the "Company") (Euronext Amsterdam: BAI), a leader in applying advanced AI to accelerate biopharma drug discovery, announces the appointment of Deutsche Numis as the Company's Financial and Capital Markets Adviser,...
YOUR LEGAL RIGHTS MAY BE AFFECTED
There is a proposed settlement in a class-action lawsuit filed against Pfizer Inc., Pfizer Ireland Pharmaceuticals, Warner-Lambert Company, and Warner-Lambert Company LLC (collectively, "Pfizer") and Ranbaxy Inc.,...
In a landmark event signaling its ambitious foray into the biopharmaceutical sector, LOTTE BIOLOGICS, under the leadership of CEO Richard W. Lee, held a groundbreaking ceremony for its inaugural plant at the Songdo Bio Campus in Incheon International...
Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing both first-in-class and best-in-class therapies for hematological malignancies, announced today that on July 2, 2024, in relation to...
Atara Biotherapeutics, Inc. , a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today announced that Pascal...